Joanne Elizabeth
Joanne Elizabeth Compson, Slough GB
Patent application number | Description | Published |
---|---|---|
20140348844 | NEUTRALISING ANTIBODIES TO THE MAJOR EXOTOXINS TCDA AND TCDB OF CLOSTRIDIUM DIFFICILE - This present invention describes the derivation and selection of antibodies capable of neutralising the major exotoxins; TcdA and TcdB of | 11-27-2014 |
Joanne Elizabeth Langride, Barnwood GB
Patent application number | Description | Published |
---|---|---|
20100186485 | Rheometer with modular environmental control system - A rheometer uses a removable integrated environmental control cartridge that includes at least one environmental control unit, at least one supply port operative to interact with the supply port for a chassis of the rheometer. It also includes at least one mechanical alignment interface that is operative to interact with the mechanical alignment interface of the chassis to align both the mobile part with respect to the fixed part and the chassis supply port with respect to the environmental control cartridge part. In another general aspect, a rheometer can use an environmental control cartridge interface operative to report an identity of the integrated environmental control cartridge to an environmental control cartridge identification interface of its chassis. | 07-29-2010 |
Joanne Elizabeth Martin, Whitechapel London GB
Patent application number | Description | Published |
---|---|---|
20120177575 | FAS (APO-1,CD95) TARGETED PLATFORMS FOR INTRACELLULAR DRUG DELIVERY - A delivery vehicle, for delivering a pharmaceutically active agent or a marker to a cell, comprising a ligand binding portion specific for a Fas Ligand, and a carrier for the pharmaceutically active agent or marker. | 07-12-2012 |
Joanne Elizabeth Thwaite, Salisbury GB
Patent application number | Description | Published |
---|---|---|
20110237500 | CECROPIN-MAGAININ HYBRID PEPTIDES - The present invention relates to a biocidal fusion peptide of SEQ ID NO: 1 or a sequence with at least 90% identity thereto, compositions such as pharmaceutical compositions comprising the same, methods of preparing the peptide, and use of the peptide in treatment, in particular for the treatment of bacterial infection and/or fungal infection and/or viral infection. | 09-29-2011 |
20110288007 | BIOCIDAL FUSION PEPTIDE COMPRISING LL-37 - The present invention relates to a biocidal fusion peptide comprising: a) a peptide LL-37 or an active fragment or active derivative thereof; b) and a further heterologous bioactive peptide or an active fragment thereof, wherein part or all of the amino acid sequence of the fusion peptide is predicted to form an alpha-helix structure for disruption of a pathogen membrane, compositions such as pharmaceutical compositions comprising the same, methods of preparing the peptide and use of the peptides in treatment, in particular for the treatment of bacterial infection and/or fungal infection and/or viral infection. | 11-24-2011 |
20130109616 | ANTIMICROBIAL PEPTIDES | 05-02-2013 |